Valbiotis SA
PAR:ALVAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valbiotis SA
PAR:ALVAL
|
FR |
|
Kemira Oyj
F:KEM
|
FI |
|
N
|
National Instruments Corp
F:NI1
|
US |
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
|
Whole Earth Brands Inc
NASDAQ:FREE
|
US |
|
iSelect Ltd
ASX:ISU
|
AU |
|
Ocean Sky International Ltd
SGX:1B6
|
SG |
|
Aviva PLC
OTC:AIVAF
|
UK |
|
Bahema Educacao SA
BOVESPA:BAHI3
|
BR |
|
T
|
Tongxin International Ltd
OTC:TXIC
|
CN |
|
K
|
Korian SE
PAR:KORI
|
FR |
|
Sprocomm Intelligence Ltd
HKEX:1401
|
CN |
|
Avenir Wellness Solutions Inc
OTC:AVRW
|
US |
|
Rectron Ltd
TWSE:2302
|
TW |
|
P
|
Petro Usa Inc
OTC:PBAJ
|
US |
|
Anjani Portland Cement Ltd
NSE:APCL
|
IN |
|
V
|
Viet Nam Petroleum Transport JSC
VN:VIP
|
VN |
Wall Street
Price Targets
ALVAL Price Targets Summary
Valbiotis SA
According to Wall Street analysts, the average 1-year price target for
ALVAL
is 2.24 EUR
with a low forecast of 2.12 EUR and a high forecast of 2.42 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALVAL's stock price target?
Price Target
2.24
EUR
According to Wall Street analysts, the average 1-year price target for
ALVAL
is 2.24 EUR
with a low forecast of 2.12 EUR and a high forecast of 2.42 EUR.
What is Valbiotis SA's Revenue forecast?
Projected CAGR
230%
For the last 8 years the
compound annual growth rate for
Valbiotis SA's revenue is
104%.
The projected
CAGR
for the next 3 years is
230%.